Financhill
Sell
6

CNSP Quote, Financials, Valuation and Earnings

Last price:
$3.67
Seasonality move :
-35.71%
Day range:
$3.63 - $4.23
52-week range:
$3.63 - $114.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.23x
Volume:
33K
Avg. volume:
57.7K
1-year change:
-94.5%
Market cap:
$2.3M
Revenue:
--
EPS (TTM):
-$40.72

Earnings Data

Next earnings date for CNSP
--
Most recent earnings per share
-$5.76
Missed by $5.76
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CNSP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -- --
12/31/2025 Q4 -- -- -- -- --
09/30/2025 Q3 -- -- -$5.76 -- --
08/14/2025 Q2 -- -- -$6.42 -- --
05/15/2025 Q1 -- -- -$1.58 -- --
12/31/2024 Q4 -- -- -$26.96 -- --
11/14/2024 Q3 -- -- -$0.25 -- --
08/14/2024 Q2 -- -- -$6.72 -- --
05/15/2024 Q1 -- -- -$20.34 -- --
12/31/2023 Q4 -- -- -$47.71 -- --
11/15/2023 Q3 -- -- -$54.14 -- --
06/30/2023 Q2 -- -- -$51.86 -- --
03/31/2023 Q1 -- -- -$129.35 -- --
12/31/2022 Q4 -- -- -$191.06 -- --
11/11/2022 Q3 -- -- -$128.13 -- --
08/12/2022 Q2 -- -- -$133.62 -- --
05/13/2022 Q1 -- -- -$2,192,778.00 -- --
03/03/2022 Q4 -- -- -$88,353.00 -- --
11/12/2021 Q3 -- -- -$208.49 -- --
08/13/2021 Q2 -- -- -$224.93 -- --
05/14/2021 Q1 -- -- -$219.75 -- --
03/12/2021 Q4 -- -- -$265.67 -- --
11/12/2020 Q3 -- -- -$183.00 -- --
08/13/2020 Q2 -- -- -$225.57 -- --
05/15/2020 Q1 -- -- -$179.46 -- --
03/12/2020 Q4 -- -- -$230.46 -- --
09/30/2019 Q3 -- -- -$64.44 -- --
06/30/2019 Q2 -- -- -$39.36 -- --
03/31/2019 Q1 -- -- -$19.29 -- --
12/31/2018 Q4 -- -- -$604.70 -- --
09/30/2018 Q3 -- -- -$17.61 -- --
06/30/2018 Q2 -- -- -$23.48 -- --
03/31/2018 Q1 -- -- -$28.25 -- --

CNS Pharmaceuticals, Inc. Earnings Questions

  • How Much did CNS Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    CNS Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did CNS Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    CNS Pharmaceuticals, Inc. announced earnings per share of -$5.76 which represents a miss of analyst forecast a -- per share.

  • Is CNS Pharmaceuticals, Inc. Profitable?

    CNS Pharmaceuticals, Inc. reported -$700 that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for CNS Pharmaceuticals, Inc. EPS Next Year?

    CNS Pharmaceuticals, Inc.'s earnings are forecast to grow from -$466.44 per share to -- per share next year representing an increase of --.

  • When is CNS Pharmaceuticals, Inc.'s Earnings Date?

    Currently, CNS Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 14, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
40
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
91
TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy
67
DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy
77
VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock